FGFR3 contributes to intestinal crypt cell growth arrest.

Area of Science:

• Gastroenterology
• Cell Biology
• Molecular Biology

Background:

• Fibroblast growth factors (FGFs) are crucial for tissue development and maintenance.
• Fibroblast growth factor receptor 3 (FGFR3) is specifically expressed in intestinal crypts, suggesting a specialized role.

Purpose of the Study:

• To investigate the role of FGFR3 in intestinal homeostasis and precursor cell proliferation.
• To elucidate the signaling pathways and molecular interactions involving FGF18 and FGFR3 in the intestine.

Main Methods:

• Utilized FGFR3-deficient mice to assess intestinal morphology and cell proliferation.
• Administered anti-FGFR3 antibodies and FGF18 ligand in wild-type mice.
• Performed in vitro studies to analyze intracellular signaling pathways (ERK, AKT).

Main Results:

• FGFR3 deficiency led to increased intestinal crypt depth and enhanced progenitor cell proliferation.
• FGF18 administration reduced intestinal crypt cell proliferation.
• ERK activation was inversely correlated with FGFR3 expression and modulated by FGF18 and FGFR3 signaling.

Conclusions:

• FGFR3 and its ligand FGF18 are key regulators of intestinal precursor cell proliferation.
• The FGF18-FGFR3 axis, through modulation of ERK and AKT pathways, controls intestinal crypt dynamics.